NCT07813442

Brief Summary

This study is being completed to test a method to promote patient-centered outcomes among people who use cannabis behaviors.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
44mo left

Started Feb 2027

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 4, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 10, 2026

Completed
5 months until next milestone

Study Start

First participant enrolled

February 1, 2027

Expected
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2030

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2030

Last Updated

September 14, 2026

Status Verified

September 1, 2026

Enrollment Period

3.6 years

First QC Date

September 4, 2026

Last Update Submit

September 9, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cannabis use

    Change in frequency of cannabis use measured by the Timeline Follow Back

    3-, 6-, 12-months

Secondary Outcomes (3)

  • Cannabis use disorder symptoms

    3-, 6-, 12-months

  • Depressive symptoms

    3-, 6-, 12-months

  • Anxiety symptoms

    3-, 6-, 12-months

Study Arms (2)

MI-BE

EXPERIMENTAL
Behavioral: Motivational and Behavioral Economics Informed Intervention

EUC

ACTIVE COMPARATOR
Behavioral: Enhanced Usual Care

Interventions

6 session telemedicine-delivered intervention with coaching sessions and small incentives for activity engagement.

MI-BE

Brief psychoeducation and referral resources

EUC

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • current cannabis use disorder
  • active cannabis use,
  • camera/technology/phone access
  • able to give informed consent.

You may not qualify if:

  • inability to speak English
  • conditions precluding informed consent, full participation, or understanding of interventions/assessments
  • past 90-day cannabis use disorder/substance use disorder treatment
  • current cancer treatment
  • medical cannabis certification for current cancer, end-of-life care, or progressive debilitating disease
  • active moderate/severe other substance use disorder(s) or injection drug use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan, Ann Arbor, Michigan 48109

Ann Arbor, Michigan, 48109, United States

Location

Study Officials

  • Erin Bonar, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR
  • Lara Coughlin, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Braden Kilpatrick

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Psychiatry

Study Record Dates

First Submitted

September 4, 2026

First Posted

September 10, 2026

Study Start (Estimated)

February 1, 2027

Primary Completion (Estimated)

September 1, 2030

Study Completion (Estimated)

September 1, 2030

Last Updated

September 14, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will not share

Locations